Global Drug of Abuse (DOA) Testing Market Insights and Forecast to 2028

Report ID: 1156398 | Published Date: Jan 2025 | No. of Page: 97 | Base Year: 2024 | Rating: 4.2 | Webstory: Check our Web story
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Drug of Abuse (DOA) Testing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Urine
        1.2.3 Saliva
        1.2.4 Hair
        1.2.5 Others
    1.3 Market by Application
        1.3.1 Global Drug of Abuse (DOA) Testing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Laboratories
        1.3.4 Workplace
        1.3.5 At-Home
        1.3.6 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Drug of Abuse (DOA) Testing Market Perspective (2017-2028)
    2.2 Drug of Abuse (DOA) Testing Growth Trends by Region
        2.2.1 Drug of Abuse (DOA) Testing Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Drug of Abuse (DOA) Testing Historic Market Size by Region (2017-2022)
        2.2.3 Drug of Abuse (DOA) Testing Forecasted Market Size by Region (2023-2028)
    2.3 Drug of Abuse (DOA) Testing Market Dynamics
        2.3.1 Drug of Abuse (DOA) Testing Industry Trends
        2.3.2 Drug of Abuse (DOA) Testing Market Drivers
        2.3.3 Drug of Abuse (DOA) Testing Market Challenges
        2.3.4 Drug of Abuse (DOA) Testing Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Drug of Abuse (DOA) Testing Players by Revenue
        3.1.1 Global Top Drug of Abuse (DOA) Testing Players by Revenue (2017-2022)
        3.1.2 Global Drug of Abuse (DOA) Testing Revenue Market Share by Players (2017-2022)
    3.2 Global Drug of Abuse (DOA) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Drug of Abuse (DOA) Testing Revenue
    3.4 Global Drug of Abuse (DOA) Testing Market Concentration Ratio
        3.4.1 Global Drug of Abuse (DOA) Testing Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Drug of Abuse (DOA) Testing Revenue in 2021
    3.5 Drug of Abuse (DOA) Testing Key Players Head office and Area Served
    3.6 Key Players Drug of Abuse (DOA) Testing Product Solution and Service
    3.7 Date of Enter into Drug of Abuse (DOA) Testing Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Drug of Abuse (DOA) Testing Breakdown Data by Type
    4.1 Global Drug of Abuse (DOA) Testing Historic Market Size by Type (2017-2022)
    4.2 Global Drug of Abuse (DOA) Testing Forecasted Market Size by Type (2023-2028)
5 Drug of Abuse (DOA) Testing Breakdown Data by Application
    5.1 Global Drug of Abuse (DOA) Testing Historic Market Size by Application (2017-2022)
    5.2 Global Drug of Abuse (DOA) Testing Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Drug of Abuse (DOA) Testing Market Size (2017-2028)
    6.2 North America Drug of Abuse (DOA) Testing Market Size by Type
        6.2.1 North America Drug of Abuse (DOA) Testing Market Size by Type (2017-2022)
        6.2.2 North America Drug of Abuse (DOA) Testing Market Size by Type (2023-2028)
        6.2.3 North America Drug of Abuse (DOA) Testing Market Share by Type (2017-2028)
    6.3 North America Drug of Abuse (DOA) Testing Market Size by Application
        6.3.1 North America Drug of Abuse (DOA) Testing Market Size by Application (2017-2022)
        6.3.2 North America Drug of Abuse (DOA) Testing Market Size by Application (2023-2028)
        6.3.3 North America Drug of Abuse (DOA) Testing Market Share by Application (2017-2028)
    6.4 North America Drug of Abuse (DOA) Testing Market Size by Country
        6.4.1 North America Drug of Abuse (DOA) Testing Market Size by Country (2017-2022)
        6.4.2 North America Drug of Abuse (DOA) Testing Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Drug of Abuse (DOA) Testing Market Size (2017-2028)
    7.2 Europe Drug of Abuse (DOA) Testing Market Size by Type
        7.2.1 Europe Drug of Abuse (DOA) Testing Market Size by Type (2017-2022)
        7.2.2 Europe Drug of Abuse (DOA) Testing Market Size by Type (2023-2028)
        7.2.3 Europe Drug of Abuse (DOA) Testing Market Share by Type (2017-2028)
    7.3 Europe Drug of Abuse (DOA) Testing Market Size by Application
        7.3.1 Europe Drug of Abuse (DOA) Testing Market Size by Application (2017-2022)
        7.3.2 Europe Drug of Abuse (DOA) Testing Market Size by Application (2023-2028)
        7.3.3 Europe Drug of Abuse (DOA) Testing Market Share by Application (2017-2028)
    7.4 Europe Drug of Abuse (DOA) Testing Market Size by Country
        7.4.1 Europe Drug of Abuse (DOA) Testing Market Size by Country (2017-2022)
        7.4.2 Europe Drug of Abuse (DOA) Testing Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Drug of Abuse (DOA) Testing Market Size (2017-2028)
    8.2 Asia-Pacific Drug of Abuse (DOA) Testing Market Size by Type
        8.2.1 Asia-Pacific Drug of Abuse (DOA) Testing Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Drug of Abuse (DOA) Testing Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Drug of Abuse (DOA) Testing Market Share by Type (2017-2028)
    8.3 Asia-Pacific Drug of Abuse (DOA) Testing Market Size by Application
        8.3.1 Asia-Pacific Drug of Abuse (DOA) Testing Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Drug of Abuse (DOA) Testing Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Drug of Abuse (DOA) Testing Market Share by Application (2017-2028)
    8.4 Asia-Pacific Drug of Abuse (DOA) Testing Market Size by Region
        8.4.1 Asia-Pacific Drug of Abuse (DOA) Testing Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Drug of Abuse (DOA) Testing Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Drug of Abuse (DOA) Testing Market Size (2017-2028)
    9.2 Latin America Drug of Abuse (DOA) Testing Market Size by Type
        9.2.1 Latin America Drug of Abuse (DOA) Testing Market Size by Type (2017-2022)
        9.2.2 Latin America Drug of Abuse (DOA) Testing Market Size by Type (2023-2028)
        9.2.3 Latin America Drug of Abuse (DOA) Testing Market Share by Type (2017-2028)
    9.3 Latin America Drug of Abuse (DOA) Testing Market Size by Application
        9.3.1 Latin America Drug of Abuse (DOA) Testing Market Size by Application (2017-2022)
        9.3.2 Latin America Drug of Abuse (DOA) Testing Market Size by Application (2023-2028)
        9.3.3 Latin America Drug of Abuse (DOA) Testing Market Share by Application (2017-2028)
    9.4 Latin America Drug of Abuse (DOA) Testing Market Size by Country
        9.4.1 Latin America Drug of Abuse (DOA) Testing Market Size by Country (2017-2022)
        9.4.2 Latin America Drug of Abuse (DOA) Testing Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Drug of Abuse (DOA) Testing Market Size (2017-2028)
    10.2 Middle East & Africa Drug of Abuse (DOA) Testing Market Size by Type
        10.2.1 Middle East & Africa Drug of Abuse (DOA) Testing Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Drug of Abuse (DOA) Testing Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Drug of Abuse (DOA) Testing Market Share by Type (2017-2028)
    10.3 Middle East & Africa Drug of Abuse (DOA) Testing Market Size by Application
        10.3.1 Middle East & Africa Drug of Abuse (DOA) Testing Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Drug of Abuse (DOA) Testing Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Drug of Abuse (DOA) Testing Market Share by Application (2017-2028)
    10.4 Middle East & Africa Drug of Abuse (DOA) Testing Market Size by Country
        10.4.1 Middle East & Africa Drug of Abuse (DOA) Testing Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Drug of Abuse (DOA) Testing Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Siemens
        11.1.1 Siemens Company Details
        11.1.2 Siemens Business Overview
        11.1.3 Siemens Drug of Abuse (DOA) Testing Introduction
        11.1.4 Siemens Revenue in Drug of Abuse (DOA) Testing Business (2017-2022)
        11.1.5 Siemens Recent Developments
    11.2 Merck
        11.2.1 Merck Company Details
        11.2.2 Merck Business Overview
        11.2.3 Merck Drug of Abuse (DOA) Testing Introduction
        11.2.4 Merck Revenue in Drug of Abuse (DOA) Testing Business (2017-2022)
        11.2.5 Merck Recent Developments
    11.3 Roche
        11.3.1 Roche Company Details
        11.3.2 Roche Business Overview
        11.3.3 Roche Drug of Abuse (DOA) Testing Introduction
        11.3.4 Roche Revenue in Drug of Abuse (DOA) Testing Business (2017-2022)
        11.3.5 Roche Recent Developments
    11.4 Thermo Fisher Scientific
        11.4.1 Thermo Fisher Scientific Company Details
        11.4.2 Thermo Fisher Scientific Business Overview
        11.4.3 Thermo Fisher Scientific Drug of Abuse (DOA) Testing Introduction
        11.4.4 Thermo Fisher Scientific Revenue in Drug of Abuse (DOA) Testing Business (2017-2022)
        11.4.5 Thermo Fisher Scientific Recent Developments
    11.5 Bio-Rad
        11.5.1 Bio-Rad Company Details
        11.5.2 Bio-Rad Business Overview
        11.5.3 Bio-Rad Drug of Abuse (DOA) Testing Introduction
        11.5.4 Bio-Rad Revenue in Drug of Abuse (DOA) Testing Business (2017-2022)
        11.5.5 Bio-Rad Recent Developments
    11.6 Abbott
        11.6.1 Abbott Company Details
        11.6.2 Abbott Business Overview
        11.6.3 Abbott Drug of Abuse (DOA) Testing Introduction
        11.6.4 Abbott Revenue in Drug of Abuse (DOA) Testing Business (2017-2022)
        11.6.5 Abbott Recent Developments
    11.7 Quest Diagnostics
        11.7.1 Quest Diagnostics Company Details
        11.7.2 Quest Diagnostics Business Overview
        11.7.3 Quest Diagnostics Drug of Abuse (DOA) Testing Introduction
        11.7.4 Quest Diagnostics Revenue in Drug of Abuse (DOA) Testing Business (2017-2022)
        11.7.5 Quest Diagnostics Recent Developments
    11.8 Psychemedics
        11.8.1 Psychemedics Company Details
        11.8.2 Psychemedics Business Overview
        11.8.3 Psychemedics Drug of Abuse (DOA) Testing Introduction
        11.8.4 Psychemedics Revenue in Drug of Abuse (DOA) Testing Business (2017-2022)
        11.8.5 Psychemedics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
List of Tables
    Table 1. Global Drug of Abuse (DOA) Testing Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Urine
    Table 3. Key Players of Saliva
    Table 4. Key Players of Hair
    Table 5. Key Players of Others
    Table 6. Global Drug of Abuse (DOA) Testing Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 7. Global Drug of Abuse (DOA) Testing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Drug of Abuse (DOA) Testing Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Drug of Abuse (DOA) Testing Market Share by Region (2017-2022)
    Table 10. Global Drug of Abuse (DOA) Testing Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Drug of Abuse (DOA) Testing Market Share by Region (2023-2028)
    Table 12. Drug of Abuse (DOA) Testing Market Trends
    Table 13. Drug of Abuse (DOA) Testing Market Drivers
    Table 14. Drug of Abuse (DOA) Testing Market Challenges
    Table 15. Drug of Abuse (DOA) Testing Market Restraints
    Table 16. Global Drug of Abuse (DOA) Testing Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Drug of Abuse (DOA) Testing Revenue Share by Players (2017-2022)
    Table 18. Global Top Drug of Abuse (DOA) Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug of Abuse (DOA) Testing as of 2021)
    Table 19. Ranking of Global Top Drug of Abuse (DOA) Testing Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Drug of Abuse (DOA) Testing Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Drug of Abuse (DOA) Testing Product Solution and Service
    Table 23. Date of Enter into Drug of Abuse (DOA) Testing Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Drug of Abuse (DOA) Testing Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Drug of Abuse (DOA) Testing Revenue Market Share by Type (2017-2022)
    Table 27. Global Drug of Abuse (DOA) Testing Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Drug of Abuse (DOA) Testing Revenue Market Share by Type (2023-2028)
    Table 29. Global Drug of Abuse (DOA) Testing Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Drug of Abuse (DOA) Testing Revenue Share by Application (2017-2022)
    Table 31. Global Drug of Abuse (DOA) Testing Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Drug of Abuse (DOA) Testing Revenue Share by Application (2023-2028)
    Table 33. North America Drug of Abuse (DOA) Testing Market Size by Type (2017-2022) & (US$ Million)
    Table 34. North America Drug of Abuse (DOA) Testing Market Size by Type (2023-2028) & (US$ Million)
    Table 35. North America Drug of Abuse (DOA) Testing Market Size by Application (2017-2022) & (US$ Million)
    Table 36. North America Drug of Abuse (DOA) Testing Market Size by Application (2023-2028) & (US$ Million)
    Table 37. North America Drug of Abuse (DOA) Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 38. North America Drug of Abuse (DOA) Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Europe Drug of Abuse (DOA) Testing Market Size by Type (2017-2022) & (US$ Million)
    Table 40. Europe Drug of Abuse (DOA) Testing Market Size by Type (2023-2028) & (US$ Million)
    Table 41. Europe Drug of Abuse (DOA) Testing Market Size by Application (2017-2022) & (US$ Million)
    Table 42. Europe Drug of Abuse (DOA) Testing Market Size by Application (2023-2028) & (US$ Million)
    Table 43. Europe Drug of Abuse (DOA) Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 44. Europe Drug of Abuse (DOA) Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Drug of Abuse (DOA) Testing Market Size by Type (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Drug of Abuse (DOA) Testing Market Size by Type (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Drug of Abuse (DOA) Testing Market Size by Application (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Drug of Abuse (DOA) Testing Market Size by Application (2023-2028) & (US$ Million)
    Table 49. Asia Pacific Drug of Abuse (DOA) Testing Market Size by Region (2017-2022) & (US$ Million)
    Table 50. Asia Pacific Drug of Abuse (DOA) Testing Market Size by Region (2023-2028) & (US$ Million)
    Table 51. Latin America Drug of Abuse (DOA) Testing Market Size by Type (2017-2022) & (US$ Million)
    Table 52. Latin America Drug of Abuse (DOA) Testing Market Size by Type (2023-2028) & (US$ Million)
    Table 53. Latin America Drug of Abuse (DOA) Testing Market Size by Application (2017-2022) & (US$ Million)
    Table 54. Latin America Drug of Abuse (DOA) Testing Market Size by Application (2023-2028) & (US$ Million)
    Table 55. Latin America Drug of Abuse (DOA) Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 56. Latin America Drug of Abuse (DOA) Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Drug of Abuse (DOA) Testing Market Size by Type (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Drug of Abuse (DOA) Testing Market Size by Type (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Drug of Abuse (DOA) Testing Market Size by Application (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Drug of Abuse (DOA) Testing Market Size by Application (2023-2028) & (US$ Million)
    Table 61. Middle East and Africa Drug of Abuse (DOA) Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 62. Middle East and Africa Drug of Abuse (DOA) Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 63. Siemens Company Details
    Table 64. Siemens Business Overview
    Table 65. Siemens Drug of Abuse (DOA) Testing Product
    Table 66. Siemens Revenue in Drug of Abuse (DOA) Testing Business (2017-2022) & (US$ Million)
    Table 67. Siemens Recent Developments
    Table 68. Merck Company Details
    Table 69. Merck Business Overview
    Table 70. Merck Drug of Abuse (DOA) Testing Product
    Table 71. Merck Revenue in Drug of Abuse (DOA) Testing Business (2017-2022) & (US$ Million)
    Table 72. Merck Recent Developments
    Table 73. Roche Company Details
    Table 74. Roche Business Overview
    Table 75. Roche Drug of Abuse (DOA) Testing Product
    Table 76. Roche Revenue in Drug of Abuse (DOA) Testing Business (2017-2022) & (US$ Million)
    Table 77. Roche Recent Developments
    Table 78. Thermo Fisher Scientific Company Details
    Table 79. Thermo Fisher Scientific Business Overview
    Table 80. Thermo Fisher Scientific Drug of Abuse (DOA) Testing Product
    Table 81. Thermo Fisher Scientific Revenue in Drug of Abuse (DOA) Testing Business (2017-2022) & (US$ Million)
    Table 82. Thermo Fisher Scientific Recent Developments
    Table 83. Bio-Rad Company Details
    Table 84. Bio-Rad Business Overview
    Table 85. Bio-Rad Drug of Abuse (DOA) Testing Product
    Table 86. Bio-Rad Revenue in Drug of Abuse (DOA) Testing Business (2017-2022) & (US$ Million)
    Table 87. Bio-Rad Recent Developments
    Table 88. Abbott Company Details
    Table 89. Abbott Business Overview
    Table 90. Abbott Drug of Abuse (DOA) Testing Product
    Table 91. Abbott Revenue in Drug of Abuse (DOA) Testing Business (2017-2022) & (US$ Million)
    Table 92. Abbott Recent Developments
    Table 93. Quest Diagnostics Company Details
    Table 94. Quest Diagnostics Business Overview
    Table 95. Quest Diagnostics Drug of Abuse (DOA) Testing Product
    Table 96. Quest Diagnostics Revenue in Drug of Abuse (DOA) Testing Business (2017-2022) & (US$ Million)
    Table 97. Quest Diagnostics Recent Developments
    Table 98. Psychemedics Company Details
    Table 99. Psychemedics Business Overview
    Table 100. Psychemedics Drug of Abuse (DOA) Testing Product
    Table 101. Psychemedics Revenue in Drug of Abuse (DOA) Testing Business (2017-2022) & (US$ Million)
    Table 102. Psychemedics Recent Developments
    Table 103. Research Programs/Design for This Report
    Table 104. Key Data Information from Secondary Sources
    Table 105. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Drug of Abuse (DOA) Testing Market Share by Type: 2021 VS 2028
    Figure 2. Urine Features
    Figure 3. Saliva Features
    Figure 4. Hair Features
    Figure 5. Others Features
    Figure 6. Global Drug of Abuse (DOA) Testing Market Share by Application: 2021 VS 2028
    Figure 7. Hospitals Case Studies
    Figure 8. Laboratories Case Studies
    Figure 9. Workplace Case Studies
    Figure 10. At-Home Case Studies
    Figure 11. Others Case Studies
    Figure 12. Drug of Abuse (DOA) Testing Report Years Considered
    Figure 13. Global Drug of Abuse (DOA) Testing Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 14. Global Drug of Abuse (DOA) Testing Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global Drug of Abuse (DOA) Testing Market Share by Region: 2021 VS 2028
    Figure 16. Global Drug of Abuse (DOA) Testing Market Share by Players in 2021
    Figure 17. Global Top Drug of Abuse (DOA) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug of Abuse (DOA) Testing as of 2021)
    Figure 18. The Top 10 and 5 Players Market Share by Drug of Abuse (DOA) Testing Revenue in 2021
    Figure 19. North America Drug of Abuse (DOA) Testing Market Size YoY (2017-2028) & (US$ Million)
    Figure 20. North America Drug of Abuse (DOA) Testing Market Size Market Share by Type (2017-2028)
    Figure 21. North America Drug of Abuse (DOA) Testing Market Size Market Share by Application (2017-2028)
    Figure 22. North America Drug of Abuse (DOA) Testing Market Size Share by Country (2017-2028)
    Figure 23. United States Drug of Abuse (DOA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Canada Drug of Abuse (DOA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Europe Drug of Abuse (DOA) Testing Market Size YoY (2017-2028) & (US$ Million)
    Figure 26. Europe Drug of Abuse (DOA) Testing Market Size Market Share by Type (2017-2028)
    Figure 27. Europe Drug of Abuse (DOA) Testing Market Size Market Share by Application (2017-2028)
    Figure 28. Europe Drug of Abuse (DOA) Testing Market Size Share by Country (2017-2028)
    Figure 29. Germany Drug of Abuse (DOA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. France Drug of Abuse (DOA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. U.K. Drug of Abuse (DOA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Italy Drug of Abuse (DOA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Russia Drug of Abuse (DOA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Nordic Countries Drug of Abuse (DOA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Asia-Pacific Drug of Abuse (DOA) Testing Market Size YoY (2017-2028) & (US$ Million)
    Figure 36. Asia Pacific Drug of Abuse (DOA) Testing Market Size Market Share by Type (2017-2028)
    Figure 37. Asia Pacific Drug of Abuse (DOA) Testing Market Size Market Share by Application (2017-2028)
    Figure 38. Asia Pacific Drug of Abuse (DOA) Testing Market Size Share by Region (2017-2028)
    Figure 39. China Drug of Abuse (DOA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Japan Drug of Abuse (DOA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. South Korea Drug of Abuse (DOA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Southeast Asia Drug of Abuse (DOA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. India Drug of Abuse (DOA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Australia Drug of Abuse (DOA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Latin America Drug of Abuse (DOA) Testing Market Size YoY (2017-2028) & (US$ Million)
    Figure 46. Latin America Drug of Abuse (DOA) Testing Market Size Market Share by Type (2017-2028)
    Figure 47. Latin America Drug of Abuse (DOA) Testing Market Size Market Share by Application (2017-2028)
    Figure 48. Latin America Drug of Abuse (DOA) Testing Market Size Share by Country (2017-2028)
    Figure 49. Mexico Drug of Abuse (DOA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 50. Brazil Drug of Abuse (DOA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 51. Middle East & Africa Drug of Abuse (DOA) Testing Market Size YoY (2017-2028) & (US$ Million)
    Figure 52. Middle East and Africa Drug of Abuse (DOA) Testing Market Size Market Share by Type (2017-2028)
    Figure 53. Middle East and Africa Drug of Abuse (DOA) Testing Market Size Market Share by Application (2017-2028)
    Figure 54. Middle East and Africa Drug of Abuse (DOA) Testing Market Size Share by Country (2017-2028)
    Figure 55. Turkey Drug of Abuse (DOA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. Saudi Arabia Drug of Abuse (DOA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 57. UAE Drug of Abuse (DOA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 58. Siemens Revenue Growth Rate in Drug of Abuse (DOA) Testing Business (2017-2022)
    Figure 59. Merck Revenue Growth Rate in Drug of Abuse (DOA) Testing Business (2017-2022)
    Figure 60. Roche Revenue Growth Rate in Drug of Abuse (DOA) Testing Business (2017-2022)
    Figure 61. Thermo Fisher Scientific Revenue Growth Rate in Drug of Abuse (DOA) Testing Business (2017-2022)
    Figure 62. Bio-Rad Revenue Growth Rate in Drug of Abuse (DOA) Testing Business (2017-2022)
    Figure 63. Abbott Revenue Growth Rate in Drug of Abuse (DOA) Testing Business (2017-2022)
    Figure 64. Quest Diagnostics Revenue Growth Rate in Drug of Abuse (DOA) Testing Business (2017-2022)
    Figure 65. Psychemedics Revenue Growth Rate in Drug of Abuse (DOA) Testing Business (2017-2022)
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Siemens
Merck
Roche
Thermo Fisher Scientific
Bio-Rad
Abbott
Quest Diagnostics
Psychemedics
Frequently Asked Questions
Drug of Abuse (DOA) Testing report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Drug of Abuse (DOA) Testing report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Drug of Abuse (DOA) Testing report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Solar Encapsulant

Solar Encapsulant market is segmented by Type and by Application. Players, stakeholders, and othe ... Read More